Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
LIBROCEF
BRANDED
Cefadroxil, Inhibits bacterial cell wall synthesis resulting in leakage of bacterial and lysis bacteria cells.
Available at :
Share this article
Related
Articles
Use of Intraarticular Hyaluronic Acid (IAHA) Injection for Shoulder Osteoarthritis
by dr. Lyon Clement | 05 Feb 2026
World Antimicrobial Resistance Awareness Week - Act Now: Protect Our Present, Secure Our Future
by dr. Dita Arccinirmala | 24 Nov 2025
Mesenchymal Stem Cell (MSC) Therapy for Osteoarthritis, What are the Results? Here is the Meta-analysis Study
by dr. Lyon Clement | 08 May 2025
.
by dr. Nugroho Nitiyoso, MBA | 19 Feb 2025
.
by dr. Desta Wulan Restu | 11 Sep 2024
'Mysterious' Pneumonia in China, These are the Facts
by dr. Vivian Keung | 01 Dec 2023
Etoricoxib Reduces Pain and Severity of Central Sensitization Signs in Osteoarthritis Patients
by dr. Johan Indra Lukito | 28 Nov 2023
Antimicrobial Misuse and Resistance
by dr. Vivian Keung | 18 Nov 2023
.
by dr. Johan Indra Lukito | 11 Aug 2023
Tofacitinib Effective for Improving Psoriatic Arthritis Symptoms
by dr. Nugroho Nitiyoso, MBA | 11 May 2023
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE